A recent study reveals the pivotal role of tristetraprolin (TTP), an RNA-binding protein, in regulating inflammatory responses in basophils, immune cells central to allergic reactions. The research shows that TTP controls the stability of mRNAs for inflammatory molecules, preventing their overproduction. Using TTP-deficient mice, the team found heightened allergic inflammation, suggesting TTP as a promising therapeutic target for treating allergic and inflammatory diseases.
Targeting tristetraprolin in basophils: A breakthrough in allergic inflammation treatment
